Cargando…

Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause

BACKGROUND: During SARS-CoV-2 infection, diffuse alveolar damage and pulmonary microvascular abnormalities are critical events that result in gas exchange disorders of varying severity and duration. The only measure of carbon monoxide (CO) diffusing capacity (DL(CO)) is unable to distinguish the alv...

Descripción completa

Detalles Bibliográficos
Autores principales: Dal Negro, Roberto W., Turco, Paola, Povero, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577559/
https://www.ncbi.nlm.nih.gov/pubmed/36268261
http://dx.doi.org/10.4081/mrm.2022.875
_version_ 1784811781739249664
author Dal Negro, Roberto W.
Turco, Paola
Povero, Massimiliano
author_facet Dal Negro, Roberto W.
Turco, Paola
Povero, Massimiliano
author_sort Dal Negro, Roberto W.
collection PubMed
description BACKGROUND: During SARS-CoV-2 infection, diffuse alveolar damage and pulmonary microvascular abnormalities are critical events that result in gas exchange disorders of varying severity and duration. The only measure of carbon monoxide (CO) diffusing capacity (DL(CO)) is unable to distinguish the alveolar from the vascular side of present and residual diffusive abnormalities, and measure of nitric oxide (NO) diffusing capacity (DL(NO)) is also recommended. Dyspnoea, despite being understudied, persists in a significant proportion of patients for several weeks after hospital discharge. The goal of this study was to look into the underlying cause of long-term dyspnoea in patients who were "clinically and radiologically recovered" from COVID pneumonia by assessing DL(CO) and DL(NO) at the same time. METHODS: Patients of both genders, aged ≥18 years, who had a CT scan showing complete resolution of COVID-related parenchymal lesions were recruited consecutively. Spirometrical volumes, blood haemoglobin, SpO(2), DL(CO), DL(NO) and capillary blood volume (Vc) were measured. Data from patients without dyspnoea (group A) and from patients still claiming dyspnoea after 12-16 weeks from their hospital discharge (group B) were statistically compared. RESULTS: Forty patients were recruited: 19 in group A and 21 in group B. Groups were comparable for their general characteristics and spirometrical volumes, that were in the normal range. Mean values for DL(CO), DL(NO) and Vc were significantly and substantially lower than predicted only in patients of group B (p<0.011; p<0.0036; p<0.02; p<0.001, respectively). The DL(NO)/ DL(CO) ratio was higher in group B (p<0.001) and inversely correlated to Vc values (-0.3636). CONCLUSIONS: The single-breath, simultaneous measurement of DL(CO), DL(NO), and Vc demonstrated that problems with blood gas exchange can persist even after parenchymal lesions have healed completely. Regardless of the normality of spirometric volumes, there was a significant reduction in lung capillary blood volume. In these patients, the cause of long-term dyspnoea may be related to hidden abnormalities in the vascular side of diffusive function. In the near future, novel therapeutic approaches against residual and symptomatic signs of long-COVID are possible.
format Online
Article
Text
id pubmed-9577559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-95775592022-10-19 Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause Dal Negro, Roberto W. Turco, Paola Povero, Massimiliano Multidiscip Respir Med Original Research Article BACKGROUND: During SARS-CoV-2 infection, diffuse alveolar damage and pulmonary microvascular abnormalities are critical events that result in gas exchange disorders of varying severity and duration. The only measure of carbon monoxide (CO) diffusing capacity (DL(CO)) is unable to distinguish the alveolar from the vascular side of present and residual diffusive abnormalities, and measure of nitric oxide (NO) diffusing capacity (DL(NO)) is also recommended. Dyspnoea, despite being understudied, persists in a significant proportion of patients for several weeks after hospital discharge. The goal of this study was to look into the underlying cause of long-term dyspnoea in patients who were "clinically and radiologically recovered" from COVID pneumonia by assessing DL(CO) and DL(NO) at the same time. METHODS: Patients of both genders, aged ≥18 years, who had a CT scan showing complete resolution of COVID-related parenchymal lesions were recruited consecutively. Spirometrical volumes, blood haemoglobin, SpO(2), DL(CO), DL(NO) and capillary blood volume (Vc) were measured. Data from patients without dyspnoea (group A) and from patients still claiming dyspnoea after 12-16 weeks from their hospital discharge (group B) were statistically compared. RESULTS: Forty patients were recruited: 19 in group A and 21 in group B. Groups were comparable for their general characteristics and spirometrical volumes, that were in the normal range. Mean values for DL(CO), DL(NO) and Vc were significantly and substantially lower than predicted only in patients of group B (p<0.011; p<0.0036; p<0.02; p<0.001, respectively). The DL(NO)/ DL(CO) ratio was higher in group B (p<0.001) and inversely correlated to Vc values (-0.3636). CONCLUSIONS: The single-breath, simultaneous measurement of DL(CO), DL(NO), and Vc demonstrated that problems with blood gas exchange can persist even after parenchymal lesions have healed completely. Regardless of the normality of spirometric volumes, there was a significant reduction in lung capillary blood volume. In these patients, the cause of long-term dyspnoea may be related to hidden abnormalities in the vascular side of diffusive function. In the near future, novel therapeutic approaches against residual and symptomatic signs of long-COVID are possible. PAGEPress Publications, Pavia, Italy 2022-09-30 /pmc/articles/PMC9577559/ /pubmed/36268261 http://dx.doi.org/10.4081/mrm.2022.875 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Research Article
Dal Negro, Roberto W.
Turco, Paola
Povero, Massimiliano
Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
title Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
title_full Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
title_fullStr Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
title_full_unstemmed Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
title_short Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
title_sort long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from covid pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577559/
https://www.ncbi.nlm.nih.gov/pubmed/36268261
http://dx.doi.org/10.4081/mrm.2022.875
work_keys_str_mv AT dalnegrorobertow longlastingdyspnoeainpatientsotherwiseclinicallyandradiologicallyrecoveredfromcovidpneumoniaaprobeforcheckingpersistingdisordersincapillarylungvolumeasacause
AT turcopaola longlastingdyspnoeainpatientsotherwiseclinicallyandradiologicallyrecoveredfromcovidpneumoniaaprobeforcheckingpersistingdisordersincapillarylungvolumeasacause
AT poveromassimiliano longlastingdyspnoeainpatientsotherwiseclinicallyandradiologicallyrecoveredfromcovidpneumoniaaprobeforcheckingpersistingdisordersincapillarylungvolumeasacause